Barclays’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Hold |
384
| – | – | ﹤0.01% | 4263 |
|
|
2025
Q1 | $2K | Sell |
384
-2,486
| -87% | -$12.9K | ﹤0.01% | 4262 |
|
|
2024
Q4 | $11K | Hold |
2,870
| – | – | ﹤0.01% | 4171 |
|
|
2024
Q3 | $26K | Hold |
2,870
| – | – | ﹤0.01% | 4028 |
|
|
2024
Q2 | $28K | Sell |
2,870
-3
| -0.1% | -$29 | ﹤0.01% | 3841 |
|
|
2024
Q1 | $39K | Sell |
2,873
-4,278
| -60% | -$58.1K | ﹤0.01% | 3865 |
|
|
2023
Q4 | $78K | Buy |
7,151
+677
| +10% | +$7.38K | ﹤0.01% | 3767 |
|
|
2023
Q3 | $66K | Hold |
6,474
| – | – | ﹤0.01% | 3472 |
|
|
2023
Q2 | $102K | Hold |
6,474
| – | – | ﹤0.01% | 3388 |
|
|
2023
Q1 | $147K | Buy |
6,474
+4,901
| +312% | +$111K | ﹤0.01% | 3326 |
|
|
2022
Q4 | $56K | Sell |
1,573
-70
| -4% | -$2.49K | ﹤0.01% | 3737 |
|
|
2022
Q3 | $64K | Sell |
1,643
-6
| -0.4% | -$234 | ﹤0.01% | 3577 |
|
|
2022
Q2 | $79K | Buy |
1,649
+740
| +81% | +$35.5K | ﹤0.01% | 3556 |
|
|
2022
Q1 | $84K | Sell |
909
-1,608
| -64% | -$149K | ﹤0.01% | 3747 |
|
|
2021
Q4 | $559K | Buy |
2,517
+1,269
| +102% | +$282K | ﹤0.01% | 2484 |
|
|
2021
Q3 | $432K | Buy |
1,248
+1,022
| +452% | +$354K | ﹤0.01% | 2659 |
|
|
2021
Q2 | $86K | Sell |
226
-1,096
| -83% | -$417K | ﹤0.01% | 3190 |
|
|
2021
Q1 | $411K | Buy |
1,322
+512
| +63% | +$159K | ﹤0.01% | 2756 |
|
|
2020
Q4 | $202K | Sell |
810
-684
| -46% | -$171K | ﹤0.01% | 2699 |
|
|
2020
Q3 | $276K | Buy |
1,494
+655
| +78% | +$121K | ﹤0.01% | 2585 |
|
|
2020
Q2 | $210K | Buy |
839
+437
| +109% | +$109K | ﹤0.01% | 2783 |
|
|
2020
Q1 | $73K | Sell |
402
-802
| -67% | -$146K | ﹤0.01% | 2943 |
|
|
2019
Q4 | $501K | Sell |
1,204
-95
| -7% | -$39.5K | ﹤0.01% | 2682 |
|
|
2019
Q3 | $327K | Sell |
1,299
-42
| -3% | -$10.6K | ﹤0.01% | 2835 |
|
|
2019
Q2 | $533K | Buy |
+1,341
| New | +$533K | ﹤0.01% | 2685 |
|